Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine
JNS: Zydus Cadila Pharmaceuticals has received approval from the Drugs Controller General of India -DCGI to begin the phase-III clinical trials with its biological therapy Pegylated Interferon alpha-2b (PegiHep) in COVID-19 …
Zydus Cadila gets DCGI nod for phase-III clinical trials of COVID-19 vaccine Read More